₹567.15 3.40 (0.60%)
04:01 PM, 24-Dec-2024₹567.15 1.05 (0.19%)
03:49 PM, 24-Dec-2024BSE : 540222
NSE : LAURUSLABS
Sector : Health care
ISIN Code : INE947Q01028
Last Updated: 24-Dec-2024 | 04:01 PM IST
Market Cap (₹ Cr) | 30,578 |
Traded Value (₹ Cr) | 1.21 |
Volume (Shares) | 21,339 |
Face Value (₹) | 2 |
52-Week High (₹) | 593.00 |
52-Week High Date | 06-Dec-2024 |
52-Week Low (₹) | 358.70 |
52-Week Low Date | 25-Jan-2024 |
All Time High (₹) | 723.55 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 59.60 |
All Time Low Date | 07-Aug-2019 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 30,578 |
EPS - TTM (₹) [C] | 2.43 |
P/E Ratio (X) [C] | 233.40 |
Face Value (₹) | 2 |
Latest Dividend (%) | 20.00 |
Latest Dividend Date | 06-Nov-2024 |
Dividend Yield (%) | 0.14 |
Book Value Share (₹) [C] | 76.67 |
P/B Ratio (₹) [C] | 7.40 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Multi Asset Allocation Fund (G) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-M) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-Q) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund (IDCW-A) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (G) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-A) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-M) | 30.11 | 5,25,000 | 0.43 |
SBI Multi Asset Allocation Fund - Direct (IDCW-Q) | 30.11 | 5,25,000 | 0.43 |
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 562.40 574.20 |
Week Low/High (₹) | 556.30 578.00 |
Month Low/High (₹) | 486.85 593.00 |
Year Low/High (₹) | 360.85 593.00 |
All time Low/High (₹) | 59.60 724.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -0.74% | -0.87% | -2.74 | -2.50% |
1 Month | 10.67% | 10.64% | -0.81 | -0.75% |
3 Month | 20.67% | 20.61% | -7.59 | -8.53% |
6 Month | 32.11% | 32.10% | 1.46 | 0.81% |
1 Year | 36.58% | 36.81% | 10.36 | 11.14% |
3 Year | 13.09% | 13.06% | 37.37 | 39.54% |
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru
Registered Office: Plot No 21 Jawaharlal Nehru, Pharma City Parawada,Visakhapatnam,Andhra Pradesh-531021 Ph: 91-891-3061222
1. What's the Laurus Labs Ltd share price today?
Laurus Labs Ltd share price was Rs 567.15 at 04:01 PM IST on 24th Dec 2024. Laurus Labs Ltd share price was up by 0.60% over the previous closing price of Rs 563.75. Laurus Labs Ltd share price trend:
2. How can I quickly analyse the performance of the Laurus Labs Ltd stock?
The performance of the Laurus Labs Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of Rs 30,578 crore.
4. What is Laurus Labs Ltd's 52-week high/low share price?
The Laurus Labs Ltd’s 52-week high share price is Rs 593.00 and 52-week low share price is Rs 358.70.
5. Is the Laurus Labs Ltd profitable?
On a consolidated basis, Laurus Labs Ltd reported a profit of Rs 42.44 crore on a total income of Rs 1,196.74 crore for the quarter ended 2024. For the year ended Sep 2024, Laurus Labs Ltd had posted a profit of Rs 17.72 crore on a total income of Rs 1,228.30 crore.
6. Which are Laurus Labs Ltd’s peers in the Health care sector?
Laurus Labs Ltd’s top 5 peers in the Health care sector are Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma, Laurus Labs, Gland Pharma, J B Chemicals &, Suven Pharma.
7. Who owns how much in Laurus Labs Ltd?
Key changes to the Laurus Labs Ltd shareholding are as follows: